Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Supplemental Screening for Breast Cancer With Abbreviated Breast MR for Black Women With Increased Breast Density

NCT04854304 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT04854304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04854304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Supplemental Screening for Breast Cancer With Abbreviated Breast MR for Black Women With Increased Breast Density
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Observational
Overall status
Active, not recruiting
Start date
September 23, 2021
Completion date
July 13, 2028
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast diseases